UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025

Om avsnittet

In this episode, experts at Boyds, Chris Moore and Shalini Gupta break down the UK Clinical Trial Regulation (UK CTR), exploring why the reform was introduced and highlighting the practical changes sponsors need to know - including new terminology, updated timelines, notifiable trials, transparency obligations, safety reporting, and labelling updates.

Listeners will gain insight into how these changes will affect trial set-up and operations, what to prepare for ahead of the 28 April 2026 implementation date, and where opportunities exist for faster, more predictable approvals.

Om avsnittet

Fler avsnitt

Live Biotherapeutics: Navigating the Next Frontier in Drug Development

How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?

Navigating the FDA Landscape: More Changes, and What's Next?

At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development

Navigating the New FDA Landscape: Opportunities and Challenges Ahead

From Lab to Launch – Avoiding the Pitfalls of Drug Development

Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025

How to Effectively De-Risk your IND Process

Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators

Patients as Partners: Advocacy's Role in Shaping Drug Development